Every year doctors detect prostate cancer in about 10,000 Poles. It is estimated that the number of patients may be higher, as men often consider prostate afflictions to be a taboo subject, and they do not admit to them. Diagnosis is made more difficult by the fact that in the initial phase of development the tumour is usually asymptomatic. Patients often come to the doctor only when they experience bone pain, which is a sign of advanced prostate cancer resulting in bone metastases. Further signs suggestive of advanced disease are haematuria, blood in the semen, and urinary retention, or hydronephrosis.
If you want to stay ahead of the disease, find out if you are at risk for prostate cancer, or perhaps you already have a referral for diagnostics, we invite you to visit our facility. At Medicover Hospital, we offer the following:
PCA3 URINE TEST
PCA3 test is an advanced genetic test of the PCA3 gene (Prostate Cancer Gene 3), having a very high sensitivity and specificity for prostate cancer. This test allows for non-invasive diagnostics of prostate cancer, qualification for biopsy or secondary biopsy, as well as assessment of progression and the aggressiveness of the tumour. Through the use of this non-invasive method for prostate cancer detection it is possible to distinguish between malignant and healthy tissues.
Who should undergo PCA3 testing, and when should it be done?
- In case of persistent suspicion of prostate cancer, despite its presence not being confirmed by a biopsy
- Men with an elevated PSA level, or an abnormal DRE (evaluation of prostate through a rectal examination), and must make a decision to undergo prostate biopsy
- Men whose free PSA levels and total PSA levels cannot definitively determine the need for prostate biopsy
- Men with a genetic predisposition for prostate cancer (if the father, uncles or grandfather suffered from prostate cancer)
- If cancer cells were detected during the prostate biopsy, and there is a need for risk assessment of progression and to predict the aggressiveness of the disease
The test is performed using a urine sample. The sample is taken during a urological consultation. The result is available in about 2 weeks. The Test costs PLN 1,800 + PLN 190 for urology visit.
4K®TEST MOLECULAR TEST
4K-Test is a test that allows estimating the risk of occurrence and development of aggressive prostate cancer, even up to 20 years in advance. The 4K-Test is a specially developed diagnostic algorithm for prostate cancer screening, which takes into account the levels of as many as four types of kallikrein in plasma. According to many experts, the 4K-Test performed by drawing blood allows men to detect prostate cancer at a very early stage of development, and is a real breakthrough in the early detection of prostate cancer.
Who should undergo the 4K-Test molecular test?
The test is recommended for men who:
- have a preliminary diagnosis and are considering undergoing primary or secondary biopsy
- have a genetic predisposition (if the father, uncles or grandfather suffered from prostate cancer)
- want to detect the disease in its early stages, when a cure is entirely possible
The test is performed using a blood sample. The sample is taken during a urological consultation. The result is available in about 4 weeks.
The test costs PLN 1,900 + PLN 190 for urology visit.
MULTIPARAMETRIC MRI OF THE PROSTATE
In the last five years, prostate cancer diagnostics have undergone a real revolution, and this is due to the multiparametric magnetic resonance imaging (mpMRI). During the MRI scanning of the prostate, the doctor may also locate areas of suspected cancer sites, and determine whether any cancel lesions have spread to other areas, such as lymph nodes.
The European Association of Urology recommends that each prostate re-biopsy is performed on the basis of the MRI scan, and the anomalies detected by the test.
Who should undergo testing?
The multiparametric MRI test of the prostate is recommended for patients who qualify for prostate biopsy.
The test takes 30 minutes and is completely painless. During the test, the patient receives an intravenous contrast.
The test costs PLN 990 + PLN 190 for urology visit.
PROSTATE BIOPSY UNDER MRI GUIDANCE
Prostate biopsy under MRI guidance allows for a more precise "navigation" during its execution. This method allows the urologist to perform a precise biopsy of suspicious sites. Based on the MRI image and the detailed description, the specialist may determine the further course of diagnostic and therapeutic action.
During the procedure, 3 to 18 samples are collected (depending on how many biopsies have been performed thus far) and how many cancer sites are visible during the prostate MRI. The procedure takes 30-60 minutes. Preparation for the procedure includes antibiotic therapy started earlier, and local or intravenous anaesthesia. The test costs PLN 1,400 without anaesthesia; PLN 1,900 with anaesthesia + PLN 190 for urology visit.
Who should undergo testing?
The procedure is performed in patients with elevated PSA, and if the digital rectal examination shows any irregularities. In addition, it is also performed if the prostate MRI reveals areas with a PI-RADSv2.0 score of 3, 4, or 5.
We invite all men who wish to undergo diagnostic tests for a consultation with an urologist, during which the doctor will order appropriate test and determine further actions.
The consultation is conducted by Dr Stefan W. Czarniecki at the Hospital Consultation Centre. The visit lasts 20 minutes.